Date | Title | | 11/30/17 | BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart StudyMALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study. The study, which launched today, is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation... |
|  | 11/27/17 | Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management ProgramMALVERN, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:BEAT) – Telcare, the manufacturer of the world’s first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily (an Alphabet company) and Sanofi. Under this partnership, Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.
Onduo will leverage... |
|  | 11/07/17 | BioTelemetry, Inc. Reports Third Quarter 2017 Financial ResultsCompany Posts Strong Growth with Integration Ahead of Schedule
Reports Record Quarterly Revenue and Adjusted EBITDA
MALVERN, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2017.
Company Highlights
Recognized highest quarterly revenue in Co... |
|  | 10/30/17 | BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017MALVERN, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2017 earnings on Tuesday, November 7th at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, November 7, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our... |
|  | 10/25/17 | BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical TrialsFirst to Market Alliance Increases Precision and Specificity while Reducing Cost
MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that BioTelemetry Research, their leading global imaging and cardiac core lab, and AMRA, the international leader in body composition analysis, have formed an exclusive alliance ... |
|  | 08/08/17 | BioTelemetry, Inc. Reports Second Quarter 2017 Financial ResultsReports Record Quarterly Revenue and EBITDA
Raises Full Year 2017 Guidance
MALVERN, Pa., Aug. 08, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2017.
Company Highlights
Recognized highest quarterly revenue in Company’s history of $58.1 million, a 10.3% increase over... |
|  | 07/31/17 | BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 8, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our webs... |
|  | 07/12/17 | BioTelemetry, Inc. Completes LifeWatch AG AcquisitionDeal Solidifies BioTelemetry’s Leadership Position in Remote Cardiac Monitoring
MALVERN, Pa. and ZUG, Switzerland, July 12, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the world’s leading wireless medical technology company focused on the delivery of health information for healthcare providers to monitor and diagnose patients accurately and cost-effectively, announces it has completed its acquisition of LifeWatch AG (SIX:LIFE).
“We are gratified that LifeWatch AG shareholde... |
|  | 07/07/17 | BioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AGMALVERN, Pa. and ZUG, Switzerland, July 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the definitive results of the tender offer for LifeWatch AG (SIX:LIFE) which concluded on June 28, 2017. The definitive results show shareholders have tendered 17,848,661 shares of LifeWatch, representing approximately 97% of the to... |
|  | 06/09/17 | BioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AGMALVERN, Pa. and ZUG, Switzerland, June 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders have tendered 15,161,925 shares of LifeWatch AG (SIX:LIFE), representing approximately 82% of the total shares outstanding. ... |
|  | 05/30/17 | LifeWatch’s Largest Shareholders Accept BioTelemetry, Inc.’s Tender Offer for LifeWatch AGMALVERN, Pa. and ZUG, Switzerland, May 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that LifeWatch’s largest shareholders, including Himalaya TMT Fund, Aevis Victoria SA and Antoine Hubert, pledged support of the Company’s tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE) and have agreed to tender th... |
|  | 05/24/17 | BioTelemetry, Inc. Increases Tender Offer Price and Extends Offer Period for LifeWatch AG SharesMALVERN, Pa. and ZUG, Switzerland, May 24, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the Company has increased the price of its previously announced public tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE). As revised, shareholders of LifeWatch will receive either CHF10.00 in cash and 0.1617 sha... |
|  | 05/23/17 | BioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG SharesMALVERN, Pa., May 23, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that, in accordance with the provisions of the Offer Prospectus and at the Company’s request, the Swiss Takeover Board has extended the initial main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE), which was schedu... |
|  | 05/10/17 | BioTelemetry, Inc. Announces the Start of the Tender Offer Period for LifeWatch AG SharesMALVERN, Pa. and ZUG, Switzerland, May 10, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the start of the main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE). The main offer period is scheduled to expire at 4:00 p.m. CEST, on May 23, 2017. It will be open for a period of ten tra... |
|  | 05/08/17 | BioTelemetry, Inc. Announces Receipt of Antitrust Clearance for its Acquisition of LifeWatch AGMALVERN, Pa. and ZUG, Switzerland , May 08, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that, effective on May 5, 2017, it received early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to its previously announced tender offer to acquire all of the capital stock of LifeWatch AG (SIX:LIFE). This clearance comes without any condition on or undertaking by BioTelemetry, LifeWatch or any ... |
|  | 05/03/17 | BioTelemetry, Inc. Reports First Quarter 2017 Financial ResultsCompany Reports Record Quarterly Revenue and Patient Volume
MALVERN, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2017.
Company Highlights
Recognized highest quarterly revenue in Company’s history of $55.9 million, a 14.9% increase over the prior year
... |
|  | 04/25/17 | BioTelemetry, Inc. to Release First Quarter 2017 Earnings Results on May 3, 2017MALVERN, Pa., April 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017. The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on o... |
|  | 04/24/17 | BioTelemetry, Inc. Issues Prospectus for Public Tender Offer to Acquire LifeWatch AGLifeWatch Board of Directors Supports BioTelemetry Tender Offer
MALVERN, Pa. and ZUG, Switzerland, April 24, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that BioTelemetry published the prospectus for the public tender offer for all publicly held registered shares of LifeWatch AG. Shareholders of LifeWatch will receive either CHF10.00 in cash and 0.1457 shares of BioTelemetry stock (“Main Offer Consideration”) (equivalent to CHF4.00 pe... |
|  | 04/09/17 | BioTelemetry, Inc. to Hold Investor Call on April 10, 2017MALVERN, Pa., April 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will hold an investor call tomorrow, April 10, 2017 at 9:00 AM Eastern Time to discuss the recently announced transaction agreement for BioTelemetry to launch a tender offer to acquire LifeWatch AG
The broadcast will be available through the investor information section of the BioTelemetry website: www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our we... |
|  | 04/09/17 | BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AGStrengthens Remote Patient Monitoring Platform
MALVERN, Pa. and ZUG, Switzerland, April 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that the companies have entered into a definitive transaction agreement under which BioTelemetry will launch a tender offer in Switzerland to acquire all of the outstanding shares of LifeWatch AG, with shareholders receiving either CHF10.00 in cash and 0.1457 shares of BioTelemetry stock (equivalent to... |
|  | 02/22/17 | BioTelemetry, Inc. Reports Fourth Quarter and Full Year 2016 Financial ResultsCompany Reports Record Results
MALVERN, Pa., Feb. 22, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year ended December 31, 2016.
Company Highlights
Recognized highest quarterly revenue in Company’s history of $54.0 million, a 15% increase over the prior year
Achieved 18... |
|  | 02/13/17 | BioTelemetry, Inc. to Release Fourth Quarter 2016 Earnings Results on February 22, 2017MALVERN, Pa., Feb. 13, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2016 earnings on Wednesday, February 22, 2017 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 22, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be avail... |
|  | 02/06/17 | Sprint & BioTelemetry, Inc. Receive a 2017 IoT Evolution Business Impact AwardAward Recognizes Businesses that Deployed Successful IoT Solutions
OVERLAND PARK, Kan., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Sprint (NYSE:S) announced today that a 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media at the IoT Evolution Conference & Expo on February 9, 2017. Sprint and BioTelemetry will present the winning case at the Expo.
The Business Impact Awards program recognizes a select group of compan... |
|  |
|